fsi_s3-90423.htm
As filed
with the Securities and Exchange Commission on May __, 2009.
Registration
No ____________
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-3
Registration
Statement
Under
THE
SECURITIES ACT OF 1933
Flexible Solutions
International, Inc.
(Exact
name of registrant as specified in charter)
(State or
other jurisdiction of incorporation)
91-1922863
|
|
615
Discovery Street
Victoria,
British Columbia
Canada V8T 5G4
|
|
(250)
477-9969
|
(IRS Employer I.D.
Number)
|
|
(Address of
principal executive offices)
|
|
(Telephone)
|
|
Daniel
B. O'Brien
615
Discovery Street
Victoria,
British Columbia
Canada
V8T 5G4
|
|
(250)
477-9969
|
|
|
(Name
and address of agent for service)
|
|
(Telephone)
|
|
Copies of
all communications, including all communications
sent
to the
agent for service, should be sent to:
William
T. Hart, Esq.
Hart
& Trinen
1624
Washington Street
Denver,
Colorado 80203
(303)
839-0061
APPROXIMATE
DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
As soon
as practicable after the effective date of this Registration
Statement
If the
only securities being registered on this Form are being offered pursuant to
dividend or interest reinvestment plans, please check the following
box. [ ]
If any of
the securities being registered on this Form are to be offered on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act of 1933, other
than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [ X ]
If this
Form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, please check the following box and list the
Securities Act registration statement number of the earlier effective
registration for the same offering. [
]
If this
Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering. [ ]
If this
Form is a registration statement pursuant to General Instruction I.D. or a
post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act, check the
following box. [ ]
If this
Form is a post-effective amendment to a registration statement filed pursuant to
General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check
the following box. [ ]
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated
filer [ ]
|
|
Accelerated
filer [ ] |
|
|
|
|
|
|
|
Non-accelerated
filer [ ] |
|
Smaller reporting
company [ X ] |
|
|
(Do not check if a
smaller reporting company) |
|
|
|
CALCULATION OF REGISTRATION
FEE |
|
|
|
|
|
|
|
|
|
|
|
|
|
Title
of each
Class
of
Securities
to
be
Registered
|
|
Maximum
Securities
to be
Registered
|
|
|
Proposed
Maximum
Offering
Price
Per
Share
(1)
|
|
|
Proposed
Aggregate
Offering
Price
|
|
|
Amount
of
Registration
Fee
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
(2) |
|
|
1,531,440 |
|
|
$ |
1.55 |
|
|
$ |
2,373,732 |
|
|
$ |
133 |
|
(1) Offering
price computed in accordance with Rule 457(c).
(2) Shares of
common stock to be sold by the selling shareholders.
The registrant hereby amends this
Registration Statement on such date or dates as may be necessary to delay its
effective date until the registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of l933 or until
the Registration Statement shall become effective on such date as the
Commission, acting pursuant to said Section 8(a), may determine.
PROSPECTUS
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
1,531,440
shares of Common Stock
By means of this prospectus a number of
the shareholders of Flexible Solutions International, Inc. are offering to sell
up to 1,531,440 shares of our common stock issuable upon the exercise of
warrants.
The securities offered by this
prospectus are speculative and involve a high degree of risk and should be
purchased only by persons who can afford to lose their entire
investment. Prospective investors should consider certain important
factors described under “Risk Factors” beginning on page 3 of this
prospectus.
These Securities Have Not Been Approved
or Disapproved by the Securities and Exchange Commission Nor Has the Commission
Passed Upon the Accuracy or Adequacy of this Prospectus. Any
Representation to the Contrary is a Criminal Offense.
Our common stock is traded on the NYSE
AMEX. On April 21, 2009 the closing price of our common stock on the
NYSE AMEX was $1.55.
The date
of this prospectus is April __, 2009
PROSPECTUS
SUMMARY
THIS
SUMMARY IS QUALIFIED BY THE MORE DETAILED INFORMATION APPEARING ELSEWHERE IN
THIS PROSPECTUS.
Our
Business
We
develop, manufacture and market specialty chemicals that slow the evaporation of
water.
Our
HEAT$AVR® product is used in swimming pools and spas. This product forms a
thin, transparent layer on the water’s surface. The transparent layer
slows the evaporation of water, allowing the water to retain a higher
temperature for a longer period of time and thereby reducing the energy required
to maintain the desired temperature of the water. Using the same
technology, our WATER$AVR® product, can also be used in reservoirs, potable
water storage tanks, livestock watering ponds, canals, and irrigation ditches
where its use slows water loss due to evaporation.
We also
manufacture and market TPA’s, or biodegradable polymers, which are used by the
petroleum, chemical, utility and mining industries to prevent corrosion and
scaling in water piping. TPA’s can also be used in detergents to
increase biodegradability and in agriculture to increase crop yields by
enhancing fertilizer uptake.
The
Offering
By means
of this prospectus a number of our shareholders are offering to sell up to
1,455,470 shares of our common stock which are issuable upon the exercise of
warrants. The warrants were sold in private offerings, together with
shares of our common stock, in 2005 and 2007. Each warrant originally
permitted the holder to purchase one share of our common stock at a price of
$4.50. On February 2, 2009 our directors lowered the exercise price
of the warrants issued in 2005 to $4.00. Also included in the shares
offered by this prospectus are 75,970 shares issuable upon the exercise of
warrants issued to sales agents participating in the private
offerings.
As of April 20, 2009 we had 14,057,567
outstanding shares of common stock. The number of outstanding shares
does not give effect to shares which may be issued upon the exercise of
outstanding warrants or options. See "Comparative Share
Data".
We will
not receive any proceeds from the sale of the shares by the selling
shareholders.
The purchase of the securities
offered by this prospectus involves a high degree of risk. Risk
factors include our history of losses and the potential need for additional
capital. See the “Risk Factors" section of this prospectus for
additional risk factors.
Forward
Looking Statements
This prospectus contains various
forward-looking statements that are based on our belief as well as assumptions
made by and information currently available to us. When used in this
prospectus, the words "believe", "expect", "anticipate", "estimate" and similar
expressions are intended to identify forward-looking statements. Such
statements may include statements regarding future revenues, payment of
operating expenses, and the like, and are subject to certain risks,
uncertainties and assumptions which could cause actual results to differ
materially from projections or estimates. Factors which could cause
actual results to differ materially are discussed at length under the heading
“Risk Factors”. Should one or more of the enumerated risks or
uncertainties materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those anticipated, estimated or
projected. Investors should not place undue reliance on
forward-looking statements, all of which speak only as of the date
made.
RISK
FACTORS
The
following is a discussion of important factors that could affect our future
operations and result in a decline in the market price of our common
stock.
We
have incurred significant operating losses since inception and may not sustain
profitability in the future.
We have
experienced operating losses and negative cash flow from operations since our
inception and we currently have an accumulated deficit. To the extent
our revenues do not increase, our results of operations and liquidity will be
materially adversely affected. If we experience slower than
anticipated revenue growth or if our operating expenses exceed our expectations,
we may not be profitable. Even if we become profitable in the future,
we may not remain profitable.
Our
failure to obtain capital may significantly restrict our operations.
We may need additional
capital to fund our operating losses and to expand our
business. We do not know what the terms of any future capital
raising may be but any future sale of our equity securities would dilute the
ownership of existing stockholders and could be at prices substantially below
the market price of the shares of common stock sold in this
offering. Our failure to obtain the capital which we require may
result in the slower implementation of our business plan or our inability to
implement our business plan. There can be no assurance that we will
be able to obtain any capital which we will need or how long we can remain in
operation.
We will
not receive any proceeds from the sale of the shares offered by this
prospectus.
Shares
issuable upon the exercise of outstanding options and warrants may substantially
increase the number of shares available for sale in the public market and may
depress the price of our common stock.
We had
outstanding options and warrants which, as of April 6, 2009, allowed the holders
to acquire a substantial number of shares of our common stock. Until
the options and warrants expire, the holders will have an opportunity to profit
from any increase in the market price of our common stock without assuming the
risks of ownership.
Holders
of options and warrants may exercise these securities at a time when we could
obtain additional capital on terms more favorable than those provided by the
options or warrants. The exercise of the options and warrants will
dilute the voting interest of the owners of presently outstanding shares by
adding a substantial number of additional shares of our common
stock. See “Comparative Share Data” for additional
information.
By means
of this registration statement, as well as other registration statements filed
with the Securities and Exchange Commission, substantially all of the shares of
common stock which are issuable upon the exercise of the outstanding options and
warrants may be sold in the public market. The sale of common stock
issued or issuable upon the exercise of our outstanding options or warrants, or
the perception that such sales could occur, may adversely affect the market
price of our common stock.
Fluctuations
in our operating results may cause our stock price to decline.
Given the
nature of the markets in which we participate, we cannot reliably predict future
revenues and profitability. Changes in competitive, market and
economic conditions may cause us to adjust our operations. A high
proportion of our costs are fixed, due in part to our sales, research and
development and manufacturing costs. Thus, small declines in revenue
could disproportionately affect our operating results. Factors that
may affect our operating results and the market price of our common stock
include:
-
demand
for and market acceptance of our products;
-
competitive
pressures resulting in lower selling prices;
-
adverse
changes in the level of economic activity in regions in which we do
business;
-
adverse
changes in industries, such as swimming pool construction, on which we are
particularly dependent;
-
changes
in the portions of our revenue represented by various products and
customers;
-
delays
or problems in the introduction of new products;
-
the
announcement or introduction of new products, services or technological
innovations by our competitors;
-
variations
in our product mix;
-
the
timing and amount of our expenditures in anticipation of future
sales;
-
increased
costs of raw materials or supplies; and
-
changes
in the volume or timing of product orders.
Our
operations are subject to seasonal fluctuation.
The use
of our swimming pool products increases in summer months in most markets and
results in our sales from January to June being greater than in July through
December. Markets for our WATER$AVR® product are also seasonal,
dependent on the wet versus dry seasons in particular countries. We
attempt to sell into a variety of countries with different seasons on both sides
of the equator in order to minimize seasonality. Our TPA business is
the least seasonal, however there is a small increase in the spring related to
inventory building for the crop season in the United States and a small slowdown
in December as oilfield customers run down stock in advance of year end, but
otherwise, little seasonal variation. We believe we are able to
adequately respond to these seasonal fluctuations by reducing or increasing
production as needed.
Interruptions
in our ability to purchase raw materials and components may adversely affect our
profitability.
We
purchase certain raw materials and components from third parties pursuant to
purchase orders placed from time to time. Because we do not have
guaranteed long-term supply arrangements with our suppliers, any material
interruption in our ability to purchase necessary raw materials or components
could have a material adverse effect on our business, financial condition and
results of operations.
Our
WATER$AVR® product has not proven to be a revenue producing product and we may
never recoup the cost associated with its development.
The
marketing efforts of our WATER$AVR® product may result in continued
losses. We introduced our WATER$AVR® product in June 2002 and, to
date, we have delivered quantities for testing by potential customers, but only
a few customers have ordered the product for commercial use. This
product can achieve success only if it is ordered in substantial quantities by
commercial customers who have determined that the water saving benefits of the
product exceed the costs of purchase and deployment of the
product. We can offer no assurance that we will receive sufficient
orders of this product to achieve profits or cover the additional expenses
incurred to manufacture and market this product.
If
we do not introduce new products in a timely manner, our products could become
obsolete and our operating results would suffer.
Without
the timely introduction of new products and enhancements, our products could
become obsolete over time, in which case our revenue and operating results would
suffer. The success of our new product offerings will depend upon
several factors, including our ability to:
-
accurately
anticipate customer needs;
-
innovate
and develop new products and applications;
-
successfully
commercialize new products in a timely manner;
-
price
our products competitively and manufacture and deliver our products in
sufficient volumes and on time; and
-
differentiate
our products from our competitors’ products.
In
developing any new product, we may be required to make a substantial investment
before we can determine the commercial viability of the new
product. If we fail to accurately foresee our customers’ needs and
future activities, we may invest heavily in research and development of products
that do not lead to significant revenues.
We
are dependent upon certain customers.
Among our
current customers, we have identified six that are sizable enough that the loss
of any one would be significant. Any such loss of one or more of
these customers could result in a substantial reduction in our
revenues. For this reason, we concentrate on maintaining good sales
relations with these customers. We also try and minimize this risk by
seeking out new customers.
Economic,
political and other risks associated with international sales and operations
could adversely affect our sales.
Shipments
made outside of the United States accounted for approximately 79% of our
revenues during the year ended December 31, 2008 and approximately 79% of our
revenues during the year ended December 31, 2007. Since we sell our
products worldwide, our business is subject to risks associated with doing
business internationally. We anticipate that revenues from
international operations will continue to represent a sizable portion of our
total revenue. Accordingly, our future results could be harmed by a
variety of factors, including:
-
changes
in foreign currency exchange rates;
-
changes
in a country or region’s political or economic conditions, particularly in
developing or emerging markets;
-
longer
payment cycles of foreign customers and difficulty of collecting receivables
in foreign jurisdictions;
-
trade
protection measures and import or export licensing
requirements;
-
differing
tax laws and changes in those laws;
-
difficulty
in staffing and managing widespread operations;
-
differing
protection of intellectual property and changes in that protection;
and
-
differing
regulatory requirements and changes in those
requirements.
We
are subject to credit risk and may be subject to substantial write-offs if one
or more of our significant customers default on their payment obligations to
us.
We
currently allow our major customers between 30 and 45 days to pay for each
shipment of product we make to them. This practice, while customary,
presents an accounts receivable write-off risk in that if one or more of our
significant customers defaulted on their payment obligations to us, such
write-off, if substantial, would have a material adverse effect on our business
and results of operations. While we have exposure to this type of
risk, we are no longer subject to the concentrated credit risk that we were
previously subject to because of our relationship with Sun Solar. In
addition, while our exposure to a bad debts and write-offs credit risk may
increase as we service a larger number of customers in the swimming pool and
personal spa, water evaporation and TPA industries, the effect of any such bad
debts and write-offs will be minimized as a result of the increase in the
numbers of our customers and overall revenues.
Our
products can be hazardous if not handled, stored and used properly; litigation
related to the handling, storage and safety of our products would have a
material adverse effect on our business and results of operations.
Some of
our products are flammable and must be stored properly to avoid fire
risk. Additionally, some of our products may cause irritation to a
person’s eyes if they are exposed to the concentrated
product. Although we label our products to warn of such risks, our
sales could be reduced if our products were to be viewed as being dangerous to
use or if they are implicated in causing personal injury or property
damage. We are not currently aware of any circumstances in which our
products have caused harm or property damage to
consumers. Nevertheless, litigation regarding the handling, storage
and safety of our products would have a material adverse effect on our business
and results of operations.
Our
failure to comply with environmental regulations may create significant
environmental liabilities and force us to modify our manufacturing
processes.
We are
subject to various federal, state and local environmental laws, ordinances and
regulations relating to the use, storage, handling and disposal of certain of
our chemical substances. Under such laws, we may become liable for
the costs of removal or remediation of these substances that have been used by
our consumers or in our operations. Such laws may impose liability
without regard to whether we knew of, or caused, the release of such
substances. Any failure by us to comply with present or future
regulations could subject us to the imposition of substantial fines, suspension
of production, alteration of manufacturing processes or cessation of operations,
any of which could have a material adverse effect on our business, financial
condition and results of operations.
Our
failure to protect our intellectual property could impair our competitive
position.
While we
own certain patents and trademarks, some aspects of our business cannot be
protected by patents or trademarks. Accordingly, in these areas there
are few legal barriers that prevent potential competitors from copying certain
of our products, processes and technologies or from otherwise entering into
operations in direct competition with us. In particular, we have been
informed that our former exclusive agent for the sale of our products, Sun
Solar, is now competing with us in the swimming pool and personal spa
markets. As a former distributor, they were given access to many of
our sales, marketing and manufacturing techniques. Accordingly, we
are doing all that we can to ensure our proprietary products and technologies
are not used by them (or others) without our permission.
Our
products may infringe on the intellectual property rights of others, and
resulting claims against us could be costly and prevent us from making or
selling certain products.
Third
parties may seek to claim that our products and operations infringe their patent
or other intellectual property rights. We may incur significant
expense in any legal proceedings to protect our proprietary rights or to defend
infringement claims by third parties. In addition, claims of third
parties against us could result in awards of substantial damages or court orders
that could effectively prevent us from making, using or selling our products in
the United States or abroad.
A
claim for damages could materially and adversely affect our financial condition
and results of operations.
Our
business exposes us to potential product liability risks, particularly with
respect to our consumer swimming pool and consumer TPA
products. There are many factors beyond our control that could lead
to liability claims, including the failure of our products to work properly and
the chance that consumers will use our products incorrectly or for purposes for
which they were not intended. There can be no assurance that the
amount of product liability insurance that we carry will be sufficient to
protect us from product liability claims. A product liability claim
in excess of the amount of insurance we carry could have a material adverse
effect on our business, financial condition and results of
operations.
Our
ongoing success is dependent upon the continued availability of certain key
employees.
Our
business would be adversely affected if the executive services of Daniel B.
O’Brien ceased to be available to us because we currently do not have any other
employee with an equivalent level of expertise in and knowledge of our
industry. If Mr. O’Brien no longer served as our President and Chief
Executive Officer, we would have to recruit one or more new executives, with no
real assurance that we would be able to engage a replacement executive with the
required skills on satisfactory terms. The market for skilled
employees is highly competitive, especially for employees in the fields in which
we operate. While our compensation programs are intended to attract
and retain the employees required for it to be successful, there can be no
assurance that we will be able to retain the services of all our key employees
or a sufficient number to execute on our plans, nor can there be any assurances
that we will be able to continue to attract new employees as
required.
COMPARATIVE
SHARE DATA
|
|
|
|
|
|
Number
Of Shares
|
|
|
Note
Reference
|
|
|
|
|
|
|
|
|
Shares
outstanding as of April 20, 2009:
|
|
|
14,057,567 |
|
|
|
|
|
|
|
|
|
|
|
|
Shares
to be sold in this Offering:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
issuable upon exercise of warrants sold to private
investors
|
|
|
1,455,470 |
|
|
|
A
|
|
|
|
|
|
|
|
|
|
|
Shares
issuable upon exercise of sales agent’s warrants
|
|
|
75,970 |
|
|
|
A
|
|
Other Shares Which May Be
Issued:
The following table lists additional
shares of our common stock which may be issued as of April 20,
2009:
|
|
Number
Of Shares
|
|
|
Note
Reference
|
|
|
|
|
|
|
|
|
Shares
issuable upon exercise of options granted
to
our officers, directors, employees, consultants,
and
third parites
|
|
|
1,910,700 |
|
|
B
|
|
|
|
|
|
|
|
|
|
|
A.
|
By
means of this prospectus a number of our shareholders are offering to sell
up to 1,455,470 shares of our common stock which are issuable upon the
exercise of warrants. The warrants were sold in private
offerings, together with shares of our common stock, in 2005 and
2007. Each warrant originally permitted the holder to purchase
one share of our common stock at a price of $4.50. On February
2, 2009 our directors lowered the exercise price of the warrants issued in
2005 to $4.00.
|
In connection with the private
offerings we paid sales commissions to Capstone Investments ($37,538), FIG
Partners, LLC ($14,251), and Barretto Securities, Inc. ($45,000). We
also issued warrants which allow: Capstone Investments to purchase 54,000 shares
of our common stock, FIG Partners to purchase 5,816 shares of our common stock,
and Barretto Securities to purchase 16,154 shares of our common
stock.
Summary
information concerning these warrants is shown below.
Shares
Issuable Upon
Exercise Of Warrants
|
Issue
Date
|
Exercise
Price
|
Expiration
Date
|
|
|
|
|
900,000
|
April
2005
|
$4.00
|
7/31/09
|
54,000
(1)
|
April
2005
|
$4.00
|
7/31/09
|
87,400
|
June
2005
|
$4.00
|
7/31/09
|
468,070
|
May
2007
|
$4.50
|
5/30/10
|
21,970
(1)
|
May
2007
|
$4.50
|
5/30/10
|
(1) Sales
agent warrants.
B.
|
Options
are exercisable at prices ranging from $1.40 to $4.55 per
share. The options expire at various dates between July 31,
2009 and May 30, 2010.
|
The shares referred to in Note A are
being offered for sale by means of this registration statement. See
“Selling Shareholders”.
The shares referred to in Note B are
being offered for sale by means of separate registration statements which have
been filed with the Securities and Exchange Commission.
MARKET
FOR OUR COMMON STOCK
Our
common stock is traded on the NYSE AMEX under the symbol “FSI”. The
following table shows the range of high and low closing prices on the NYSE AMEX
for our common stock for the periods indicated. The market quotations
reflect inter-dealer prices, without retail mark-up, mark-down or commissions
and may not necessarily represent actual transactions.
|
|
|
High
|
|
|
Low
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2007
|
First
Quarter
|
|
$ |
3.55 |
|
|
$ |
2.25 |
|
|
Second
Quarter
|
|
|
4.30 |
|
|
|
2.45 |
|
|
Third
Quarter
|
|
|
3.25 |
|
|
|
2.50 |
|
|
Fourth
Quarter
|
|
|
4.12 |
|
|
|
2.80 |
|
|
|
|
|
|
|
|
|
|
|
Year
Ended December 31, 2008
|
First
Quarter
|
|
$ |
2.24 |
|
|
$ |
1.43 |
|
|
Second
Quarter
|
|
|
2.80 |
|
|
|
2.09 |
|
|
Third
Quarter
|
|
|
2.48 |
|
|
|
1.59 |
|
|
Fourth
Quarter
|
|
|
4.12 |
|
|
|
2.80 |
|
As of
April 20, 2009 we had approximately 1,700 shareholders.
Our
common stock also trades on the Frankfurt stock exchange under the symbol
“FXT.”
We have
not paid any dividends on our common stock, and it is not anticipated that any
dividends will be paid in the foreseeable future. Our board of
directors intends to follow a policy of retaining earnings, if any, to finance
our growth. The declaration and payment of dividends in the future
will be determined by the board of directors in light of conditions then
existing, including our earnings, financial condition, capital requirements and
other factors.
SELLING
SHAREHOLDERS AND PLAN OF DISTRIBUTION
By means
of this prospectus a number of our shareholders are offering to sell up to
1,455,470 shares of our common stock which are issuable upon the exercise of
warrants. The warrants were sold in private offerings, together with
shares of our common stock, in 2005 and 2007. Each warrant originally
permitted the holder to purchase one share of our common stock at a price of
$4.50. On February 2, 2009 our directors lowered the exercise price
of the warrants issued in 2005 to $4.00.
Included in the shares offered by this
prospectus are 75,970 shares issuable upon the exercise of warrants issued to
Capstone Investments, FIG Partners, LLC, and Barretto Securities, all of which
were sales agents who participated in the private offerings.
We will not receive any proceeds from
the sale of the shares by the selling shareholders. We will pay all
costs of this offering. The selling shareholders will pay all sales
commissions and other costs relating to the sale of their shares.
Name
|
|
Shares
Owned
|
|
|
Shares
Issuable
Upon
Exercise
of Warrants
|
|
|
Shares
to
Be
Sold
in
this
Offering
|
|
|
Share
Ownership
After
Offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SF
Capital Partners, Ltd.
|
|
|
-- |
|
|
|
400,000 |
|
|
|
400,000 |
|
|
|
-- |
|
Catalina
Capital
|
|
|
-- |
|
|
|
140,000 |
|
|
|
140,000 |
|
|
|
-- |
|
HSBC
Guyerzeller
|
|
|
-- |
|
|
|
100,000 |
|
|
|
100,000 |
|
|
|
-- |
|
Perritt
Emerging Opportunities Fund
|
|
|
-- |
|
|
|
100,000 |
|
|
|
100,000 |
|
|
|
-- |
|
Nite
Capital, L.P.
|
|
|
-- |
|
|
|
70,000 |
|
|
|
70,000 |
|
|
|
-- |
|
Bluegrass
Growth Fund, L.P.
|
|
|
-- |
|
|
|
34,000 |
|
|
|
34,000 |
|
|
|
-- |
|
Bluegrass
Growth Fund, Ltd.
|
|
|
-- |
|
|
|
34,000 |
|
|
|
34,000 |
|
|
|
-- |
|
Alexander
Klinkman
|
|
|
-- |
|
|
|
22,000 |
|
|
|
22,000 |
|
|
|
-- |
|
Capstone
Investments
|
|
|
-- |
|
|
|
54,000 |
|
|
|
54,000 |
|
|
|
-- |
|
Pictet
Asset Management
|
|
|
-- |
|
|
|
87,400 |
|
|
|
87,400 |
|
|
|
-- |
|
Rohn
and Bodmer Banquiers
|
|
|
-- |
|
|
|
153,845 |
|
|
|
153,845 |
|
|
|
-- |
|
Joylen
F. Stern
|
|
|
-- |
|
|
|
38,500 |
|
|
|
38,500 |
|
|
|
-- |
|
William
G. Spears
|
|
|
-- |
|
|
|
38,500 |
|
|
|
38,500 |
|
|
|
-- |
|
William
G. Spears Profit Sharing Plan
|
|
|
-- |
|
|
|
38,500 |
|
|
|
38,500 |
|
|
|
-- |
|
Glacier
Partners LP
|
|
|
-- |
|
|
|
115,385 |
|
|
|
115,385 |
|
|
|
-- |
|
Pictet
Asset Management
|
|
|
-- |
|
|
|
46,800 |
|
|
|
46,800 |
|
|
|
-- |
|
North
Point Partners I LLC
|
|
|
-- |
|
|
|
36,540 |
|
|
|
36,540 |
|
|
|
-- |
|
FIG
Partners, LLC
|
|
|
-- |
|
|
|
5,816 |
|
|
|
5,816 |
|
|
|
-- |
|
Barretto
Securities
|
|
|
-- |
|
|
|
16,154 |
|
|
|
16,154 |
|
|
|
-- |
|
The controlling person of each selling
shareholder, which is not an individual, is shown below:
|
Selling
Shareholder
|
|
Controlling
Person
|
|
|
|
|
|
|
|
Capstone
Investments |
|
Steve
Capozza |
|
|
William G. Spears
Profit Sharing Plan |
|
William G.
Spears |
|
|
Glacier Partners
LP |
|
Peter
Castellanos |
|
|
Pictet Asset
Management |
|
Philippe Rohner or
Hans Peter Portner |
|
|
North Point Partners
I LLC |
|
Peter
Imber |
|
|
FIG Partners,
LLC |
|
Geoffrey
Hodgson |
|
|
Barretto
Securities |
|
Landon
Barretto |
|
None of the selling shareholders had or
ever had, any material relationship with us or our officers or
directors. To our knowledge, none of the selling shareholders are
affiliated with a broker dealer except for Capstone Investments, FIG Partners,
LLC, and Barretto Securities.
Manner of
Sale
The shares of common stock to be sold
by the selling shareholders may be offered and sold by means of this prospectus
from time to time as market conditions permit. These shares may be
sold by one or more of the following methods, without limitation:
-
a block
trade in which a broker or dealer so engaged will attempt to sell the shares
as agent but may position and resell a portion of the block as principal to
facilitate the transaction;
-
purchases
by a broker or dealer as principal and resale by such broker or dealer for its
account pursuant to this prospectus;
-
ordinary
brokerage transactions and transactions in which the broker solicits
purchasers; and
-
face-to-face
transactions between sellers and purchasers without a
broker/dealer.
In
competing sales, brokers or dealers engaged by the selling shareholders may
arrange for other brokers or dealers to participate. Brokers or
dealers may receive commissions or discounts from the selling shareholders in
amounts to be negotiated. As to any particular broker-dealer, this
compensation might be in excess of customary commissions. We cannot
and the selling shareholders cannot presently estimate the amount of such
compensation. Notwithstanding the above, no NASD member will charge
commissions that exceed 8% of the total proceeds from the sale.
The selling shareholders and any
broker/dealers who act in connection with the sale of the shares may be deemed
to be "underwriters" within the meaning of §2(11) of the Securities Acts of
1933, and any commissions received by them and any profit on any resale of the
shares as principal might be deemed to be underwriting discounts and commissions
under the Securities Act.
If any selling shareholder enters into
an agreement to sell its shares to a broker-dealer as principal, and the
broker-dealer is acting as an underwriter, we will file a post-effective
amendment to the registration statement, of which this prospectus is a part,
identifying the broker-dealer, providing required information concerning the
plan of distribution, and otherwise revising the disclosures in this prospectus
as needed. We will also file the agreement between the selling
shareholder and the broker-dealer as an exhibit to the post-effective amendment
to the registration statement.
The selling shareholders may also sell
their shares pursuant to Rule 144 under the Securities Act of 1933.
We have has advised the selling
shareholders that they, and any securities broker/dealers or others who may be
deemed to be statutory underwriters, will be subject to the prospectus delivery
requirements under the Securities Act of 1933. We have has also
advised the selling shareholders that in the event of a "distribution" of the
shares owned by the selling shareholders, the selling shareholders, any
"affiliated purchasers", and any broker/dealer or other person who participate
in the distribution may be subject to Rule 102 of Regulation M under the
Securities Exchange Act of 1934 ("1934 Act") until their participation in the
distribution is completed. Rule 102 makes it unlawful for any person
who is participating in a distribution to bid for or purchase stock of the same
class as is the subject of the distribution. A "distribution" is
defined in Rule 102 as an offering of securities "that is distinguished from
ordinary trading transactions by the magnitude of the offering and the presence
of special selling efforts and selling methods". We have has also
advised the selling shareholders that Rule 101 of Regulation M under the 1934
Act prohibits any "stabilizing bid" or "stabilizing purchase" for the purpose of
pegging, fixing or stabilizing the price of the common stock in connection with
this offering.
DESCRIPTION
OF SECURITIES
Common
Stock
We are authorized to issue 50,000,000
shares of common stock. Holders of common stock are each entitled to
cast one vote for each share held of record on all matters presented to
shareholders. Cumulative voting is not allowed; hence, the holders of
a majority of the outstanding common stock can elect all directors.
Holders of common stock are entitled to
receive dividends as may be declared by our Board of Directors out of funds
legally available and, in the event of liquidation, to share pro rata in any
distribution of our assets after payment of liabilities. Our
directors are not obligated to declare a dividend. It is not
anticipated that dividends will be paid in the foreseeable future.
Holders of our common stock do not have
preemptive rights to subscribe to additional shares if issued. There are no
conversion, redemption, sinking fund or similar provisions regarding our common
stock. All our outstanding shares are fully paid and
non-assessable.
Preferred
Stock
We are authorized to issue 1,000,000
shares of preferred stock. Our Articles of Incorporation provide that
our Board of Directors has the authority to divide the preferred stock into
series and, within the limitations provided by Nevada law, to fix by resolution
the voting power, designations, preferences, and relative participation, special
rights, and the qualifications, limitations or restrictions of the shares of any
series established. As our Board of Directors has authority to
establish the terms of, and to issue, the preferred stock without shareholder
approval, the preferred stock could be issued to defend against any attempted
takeover.
Options
and Warrants
See the “Comparative Share Data”
section of this prospectus for information concerning our outstanding options
and warants.
Transfer
Agent
Computershare Trust Company, Inc., of
Golden, Colorado, is the transfer agent for our common stock.
INDEMNIFICATION
The Nevada Revised Statutes authorize
indemnification of any of our directors or officers against expenses incurred in
connection with any action, suit, or proceeding to which the director or officer
is named a party by reason of his or her having acted or served in such
capacity, except for liabilities arising from his or her own misconduct or
negligence. In addition, a director or officer who was found liable
for misconduct or negligence may obtain such indemnification if, in view of all
the circumstances in the case, a court of competent jurisdiction determines such
person is fairly and reasonably entitled to indemnification. Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may
be permitted to our directors or officers, pursuant to the foregoing provisions,
we have been informed that in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in the
Act and is therefore unenforceable.
ADDITIONAL
INFORMATION
We are subject to the requirements of
the Securities Exchange Act of l934 and are required to file reports, proxy
statements and other information with the Securities and Exchange
Commission. Copies of any such reports, proxy statements and other
information which we have filed can be read and copied at the Commission’s
Public Reference Room at 100 F. Street, N.E., Washington, D.C.
20549. The public may obtain information on the operation of the
Public Reference Room by calling the Commission at
1-800-SEC-0330. The Commission maintains an Internet site that
contains reports, proxy and information statements, and other information
regarding us. The address of that site is
http://www.sec.gov.
We will provide, without charge, to
each person to whom a copy of this prospectus is delivered, including any
beneficial owner, upon the written or oral request of such person, a copy of any
or all of the documents incorporated by reference below (other than exhibits to
these documents, unless the exhibits are specifically incorporated by reference
into this prospectus).
Requests
should be directed to:
Flexible
Solutions International, Inc.
615
Discovery Street
Victoria,
British Columbia,
Canada
V8T 5G4
(250)
477-9969
The following documents we filed with
the Commission (Commission File No. 0-29649) are incorporated by reference into
this prospectus:
|
(1)
|
Annual
Report on Form 10-K for our fiscal year ended December 31,
2008.
|
|
(2)
|
Proxy
statement relating to our June 26, 2008 shareholders’
meeting.
|
All documents filed with the Securities
and Exchange Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of this prospectus and prior to the
termination of this offering shall be deemed to be incorporated by reference
into this prospectus and to be a part of this prospectus from the date of the
filing of such documents. Any statement contained in a document
incorporated or deemed to be incorporated by reference shall be deemed to be
modified or superseded for the purposes of this prospectus to the extent that a
statement contained in this prospectus or in any subsequently filed document
which also is or is deemed to be incorporated by reference herein modifies or
supersedes such statement. Any statement so modified or superseded
shall not be deemed, except as so modified or superseded, to constitute a part
of this prospectus.
Investors are entitled to rely upon
information in this prospectus or incorporated by reference at the time we use
the prospectus to offer and sell securities, even though that information may be
superseded or modified by information subsequently incorporated by reference
into this prospectus.
We have filed with the Securities and
Exchange Commission a Registration Statement under the Securities Act of l933,
as amended, with respect to the securities offered by this
prospectus. This prospectus does not contain all of the information
set forth in the Registration Statement. For further information,
reference is made to the Registration Statement and to the exhibits filed with
the Registration Statement. Statements contained in this prospectus
as to the contents of any contract or other documents are summaries which are
not necessarily complete, and in each instance reference is made to the copy of
such contract or other document filed as an exhibit to the Registration
Statement, each such statement being qualified in all respects by such
reference. The Registration Statement and related exhibits may also
be examined at the Commission’s internet site.
No dealer salesman or other person has
been authorized to give any information or to make any representations, other
than those contained in this prospectus. Any information or
representation not contained in this prospectus must not be relied upon as
having been authorized by us. This prospectus does not constitute an
offer to sell, or a solicitation of an offer to buy, the securities offered
hereby in any state or other jurisdiction to any person to whom it is unlawful
to make such offer or solicitation. Neither the delivery of this
prospectus nor any sale made hereunder shall, under any circumstances, create an
implication that there has been no change in our affairs since the date of this
prospectus.
TABLE OF
CONTENTS
|
Page
|
|
|
Prospectus
Summary
|
2
|
Risk
Factors |
3
|
Comparative Share
Data |
9
|
Market for Our
Common Stock |
10
|
Selling
Shareholders |
11
|
Description of
Securities |
13
|
Indemnification |
14
|
Additional
Information |
15
|
Common
stock
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
PROSPECTUS
PART
II
Information
Not Required in Prospectus
Item
14.
|
Other Expenses of
Issuance and Distribution
|
SEC
Filing Fee
|
|
$ |
133 |
|
Legal
Fees and Expenses
|
|
|
10,000 |
|
Accounting
Fees and Expenses
|
|
|
3,000 |
|
Miscellaneous
Expenses
|
|
|
1,867 |
|
TOTAL
|
|
$ |
15,000 |
|
All expenses other than the SEC filing
fees are estimated.
Item
15.
|
Indemnification
of Directors and Officers.
|
Section 78.7502 of the Nevada Revised
Statutes and the Company’s Bylaws provides that the Company may indemnify its
officers or directors, or former officers or directors, against expenses
actually and necessarily incurred by them in connection with the defense of any
legal proceeding or threatened legal proceeding, except as to matters in which
such persons shall be determined to not have acted in good faith and in the best
interest of the Company.
3.1
|
Amended
and Restated Certificate of Incorporation (1)
|
3.2 |
Bylaws (1) |
5. |
Opinion
of Counsel
|
21.1 |
Subsidiaries
(2)
|
23(a) |
Consent
of Hart & Trinen
|
23(b) |
Consent
of Cinnamon Jang Willoughby &
Company
|
(1)
|
Incorporated
by reference to the same exhibit number filed with the Company’s
Registration Statement on Form
10-SB.
|
(2)
|
Incorporated
by reference to the same exhibit filed with the Company’s Registration
Statement on Form SB-2 (File No.
333-100129).
|
The undersigned Registrant hereby
undertakes:
(1) To
file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement.
(i) To
include any prospectus required by Section l0(a)(3) of the Securities Act of
l933;
(ii) To
reflect in the prospectus any facts or events arising after the effective date
of the Registration Statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the Registration Statement;
(iii) To
include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to
such information in the Registration Statement, including (but not limited to)
any addition or deletion of a managing underwriter.
(2) That,
for the purpose of determining any liability under the Securities Act of l933,
each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.
(3) To
remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the
offering.
(4) That,
for purposes of determining any liability under the Securities Act of 1933, each
filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan’s annual report pursuant to Section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering
thereof.
Insofar as indemnification for
liabilities arising under the Securities Act of l933 may be permitted to
directors, officers and controlling persons of the Registrant, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question of whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
POWER
OF ATTORNEY
The registrant and each person whose
signature appears below hereby authorizes the agent for service named in this
Registration Statement, with full power to act alone, to file one or more
amendments (including post-effective amendments) to this Registration Statement,
which amendments may make such changes in this Registration Statement as such
agent for service deems appropriate, and the Registrant and each such person
hereby appoints such agent for service as attorney-in-fact, with full power to
act alone, to execute in the name and in behalf of the Registrant and any such
person, individually and in each capacity stated below, any such amendments to
this Registration Statement.
SIGNATURES
Pursuant to the requirements of the
Securities Act of l933, the Registrant certifies that it has reasonable grounds
to believe that it meets all the requirements for filing on Form S-3 and has
duly caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Victoria, British
Columbia, Canada on the 28th day of April, 2009.
|
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC. |
|
|
|
|
|
|
By:
|
/s/ DANIEL
O'BRIEN |
|
|
|
Daniel
O’Brien, President, Chief Executive Officer and
Principal
Financial and Accounting Officer
|
|
|
|
|
|
Pursuant to the requirements of the
Securities Act of l933, this Registration Statement has been signed by the
following persons in the capacities and on the dates indicated.
Signature
|
|
Title |
|
Date |
|
|
|
|
|
/s/ Daniel B.
O'Brien |
|
|
|
|
Daniel B.
O’Brien |
|
Director |
|
April 28,
2009 |
|
|
|
|
|
/s/ John H.
Bientjes |
|
|
|
|
John H.
Bientjes |
|
Director |
|
April 24,
2009 |
|
|
|
|
|
/s/ Robert N.
O'Brien |
|
|
|
|
Robert N.
O’Brien |
|
Director |
|
April 29,
2009 |
|
|
|
|
|
/s/ Dale
Friend |
|
|
|
|
Dale
Friend |
|
Director |
|
April 30,
2009 |
|
|
|
|
|
/s/ Eric G.
Hodges |
|
|
|
|
Eric G.
Hodges |
|
Director |
|
April 30,
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3